Bio-Techne Corp (TECH)

Debt-to-equity ratio

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	2,068,850	2,014,380	1,963,560	1,997,750	1,966,520	1,889,690	1,827,110	1,751,150	1,701,770	1,714,380	1,702,990	1,639,360	1,562,970	1,539,450	1,521,920	1,439,280	1,381,190	1,291,270	1,323,350	1,174,220
Debt-to-equity ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

June 30, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $2,068,850K
= 0.00

Bio-Techne Corp consistently reported a debt-to-equity ratio of 0.00 in each of the periods listed. A debt-to-equity ratio of 0.00 indicates that the company has no debt in relation to its equity. This implies that Bio-Techne Corp has been financing its operations primarily through equity rather than debt.

Having a debt-to-equity ratio of 0.00 can be viewed positively, as it suggests that the company is not relying on borrowed funds to finance its operations, which can reduce financial risk and interest expense. It also indicates a strong financial position and stability, as there is no debt pressure on the company's equity holders.

However, it's important to consider that a very low or zero debt-to-equity ratio may also mean the company is not taking advantage of potential tax benefits associated with debt financing. Overall, Bio-Techne Corp's consistent 0.00 debt-to-equity ratio reflects a prudent and conservative financial strategy with a focus on equity financing.